Evaluation of risk factors for extrahepatic cholangiocarcinoma: ABO blood group, hepatitis B virus and their synergism.

@article{Zhou2013EvaluationOR,
  title={Evaluation of risk factors for extrahepatic cholangiocarcinoma: ABO blood group, hepatitis B virus and their synergism.},
  author={Yu Zhou and Quanbo Zhou and Qing Lin and Ruiwan Chen and Yuanfeng Gong and Yiming Liu and Min Yu and Bing Zeng and Kaiwen Li and Rufu Chen and Zhihua Li},
  journal={International journal of cancer},
  year={2013},
  volume={133 8},
  pages={1867-75}
}
Little is known about the role of association between ABO blood group and development of extrahepatic cholangiocarcinoma (ECC) through effects on hepatitis B viral (HBV) infection. Our aim was to address this question using a matched case-control study in Southern China.We prospectively analyzed 239 ECC patients, and 478 age- and sex-matched controls in Sun Yat-sen Memorial Hospital of Sun Yat-sen University from 1999 to 2011. Information on ABO blood group, HBV infection and other… CONTINUE READING
Highly Cited
This paper has 27 citations. REVIEW CITATIONS
Related Discussions
This paper has been referenced on Twitter 3 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 14 extracted citations

Effect of Nucleos(t)ide Analogue Therapy on Risk of Intrahepatic Cholangiocarcinoma in Patients With Chronic Hepatitis B.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association • 2018

Similar Papers

Loading similar papers…